Adoption, Surrogacy, and IVF: How the Wealthy Build Families

The Million Dollar Question: A full surrogacy journey in the United States typically costs about as much as what?
A) A luxury car B) A starter home in much of the country C) A year of private school D) A nice watch

Read on for the answer.

Money can’t fix biology. What it can do is buy more chances to beat it — and that distinction explains almost everything about how wealthy families are built when the ordinary route doesn’t work. This piece walks through the three tools that do the heavy lifting — IVF, egg and embryo freezing, and surrogacy — plus the quieter decline of adoption, and what each one actually costs.

What it is

There are really four separate things bundled under “family building,” and they solve different problems.

In vitro fertilization (IVF) is the base layer. Eggs are retrieved from the ovaries, fertilized with sperm in a lab, grown into embryos over five or six days, and one is transferred to a uterus. Almost everything else in modern fertility medicine is a variation or an add-on to this core process.

Egg and embryo freezing is IVF’s front half, done early and paused. A woman goes through the same stimulation and retrieval, but instead of transferring an embryo now, the eggs (or embryos, if fertilized) are frozen and stored for later. It’s a bet against time — a way to bank younger, healthier eggs before age erodes them.

Surrogacy solves a different problem entirely: someone who can produce an embryo but can’t or shouldn’t carry a pregnancy. In gestational surrogacy — the standard arrangement today — a gestational carrier is implanted with an embryo she has no genetic connection to, and carries the baby to term for the intended parents.

Adoption, the oldest path of all, is the one that has quietly shrunk the most, especially the international version once associated with wealthy and famous families. It’s worth flagging up front that adoption is not really a cheaper substitute for the medical routes — a completed domestic infant or international adoption can itself run into the tens of thousands of dollars in agency, legal, and travel costs, and the supply of available children has fallen sharply.

The through-line: as you move from IVF to surrogacy, you’re adding people, contracts, and money to route around a specific biological obstacle. Wealth mostly buys the ability to keep adding.

Who uses it

The users span every wealth band, but what they buy scales sharply with money.

At the $1M–$5M level, fertility care usually means IVF — often several rounds — paid substantially out of pocket. These are households that can absorb $20,000 or $40,000 in cycles without ruin but still feel every dollar. Egg freezing shows up here too, increasingly among professional women in their early thirties treating it as insurance.

Higher up, at $5M–$30M and beyond, surrogacy enters the picture, because it’s the first tool priced out of reach for most people. So do the frequent flyers of fertility: parents who freeze a dozen embryos, test them all, and try transfer after transfer without the cost ever being the binding constraint.

Certain groups lean on these tools regardless of wealth, but wealth removes the friction for all of them: same-sex male couples, for whom surrogacy is the primary route to a genetic child; single people building families by choice; and cancer patients who freeze eggs, sperm, or embryos before chemotherapy — a field called oncofertility — to preserve the option of children after treatment. What money changes for each group isn’t eligibility but speed and discretion: a shorter path to a carrier, a clinic willing to work around a demanding travel schedule, and the privacy to keep the whole process out of view.

And then there’s the group the tabloids notice: older men starting second and third families late in life. Robert De Niro welcomed his seventh child at 79 in 2023, and Al Pacino became a father at 83 the same year. Elon Musk, by reporting in outlets including The Wall Street Journal and Axios, has fathered well more than a dozen children with several mothers, some via IVF. These cases aren’t representative, but they illustrate a real edge money buys: the ability to keep the timeline of parenthood open long after biology would ordinarily close it.

Why they use it

The obvious answer — “because they want children and can afford help” — is true but incomplete. The more useful lens is that wealthy families use these tools to buy probability, timing, and outcomes, not a product.

Probability is the core of it. A single IVF cycle is a coin flip weighted heavily by age, and the biggest predictor of a live birth is simply how many good embryos you can generate and transfer. Money buys more retrievals, more embryos, more attempts — which mechanically raises the odds even when the per-cycle success rate is fixed. A family that can comfortably fund six cycles is playing a very different game than one that can barely fund one.

Timing is what egg freezing buys. A woman who banks eggs at 32 has, in effect, purchased optionality — she’s decoupled the decision to have children from the biological clock, and can spend her thirties on a career or a search for the right partner without the same penalty. This is one of the clearest cases of the time-and-optionality logic that runs through wealthy decision-making generally.

Outcomes — carefully — is what genetic testing and surrogacy add. Preimplantation genetic testing screens embryos for chromosomal problems before transfer, reducing miscarriage risk and the odds of certain conditions. Surrogacy lets a genetic parent have a biological child when pregnancy itself is impossible or dangerous. None of this guarantees a healthy baby. But each tool shifts the odds, and shifting odds is exactly what a large budget is good for.

There’s a fourth motive that rarely gets said out loud: control over the story. Wealthy families often value privacy above almost everything, and building a family through IVF or surrogacy can be done quietly, on the family’s own timeline, without the public visibility of, say, an adoption process or a scramble late in life. The ability to plan parenthood as a deliberate project — rather than leave it to chance and timing — is itself part of what the money is buying.

How it works

A standard IVF cycle runs on a fixed sequence. The patient takes injectable hormones for roughly ten to twelve days to stimulate the ovaries to mature many eggs at once instead of the usual one. The eggs are retrieved in a short outpatient procedure under sedation. In the lab, they’re fertilized — often by injecting a single sperm directly into each egg — and the resulting embryos are grown for five to six days. Some or all are biopsied for genetic testing. Then one embryo is transferred to the uterus; the rest are frozen for later.

Egg freezing is the same process stopped after retrieval: the eggs are frozen in liquid nitrogen and stored, sometimes for a decade or more, until the person is ready to fertilize and transfer.

When a family needs donor material, another layer of choices opens up. Donor sperm and donor eggs can be sourced from banks or matched through agencies, and families can pick between anonymous donors and known ones, screen for medical history, and — at higher budgets — search for donors with specific traits. This is one of the more ethically contested corners of the field, and it’s also one where money widens the menu: more donors to choose from, faster matching, and the ability to fund the full donor cycle on top of everything else.

Surrogacy wraps a legal and logistical machine around that medical core. An agency matches intended parents with a screened gestational carrier. Lawyers on both sides draft a gestational carrier agreement covering compensation, medical decisions, and parental rights. An escrow company holds and disburses the carrier’s payments. An embryo — created through IVF using the intended parents’ or donors’ genetic material — is transferred to the carrier, who carries the pregnancy under medical supervision. After birth, a legal step (a pre-birth or post-birth order, depending on the state) establishes the intended parents as the legal parents. It’s less a medical procedure than a coordinated project with a doctor, an agency, two law firms, an escrow agent, and an insurer all involved.

The wealthy don’t get a different biology here — they get a smoother version of the same machine: shorter waits for a carrier, more attentive coordination, and the budget to absorb a failed transfer and simply start the next one.

Money also buys around the two chokepoints that stall everyone else. The first is the carrier shortage — screened, healthy gestational carriers are scarce, and agencies maintain waitlists; families willing to pay top-of-market compensation and agency fees move up those lists faster. The second is geography: surrogacy law is set state by state in the U.S., and a family with the means to work with a clinic and law firm in a surrogacy-friendly state avoids the legal limbo that trips up people who start the process where the rules are hostile.

What it costs

Here’s where the wealth gradient becomes concrete. Use the standard brackets and treat every figure as a range, because clinic, city, and how many tries you need move the number enormously.

IVF. A single cycle in the U.S. in 2025 runs roughly $20,000 to $25,000 all-in once medications, lab work, and monitoring are counted, according to figures aggregated from ASRM, FertilityIQ, and major clinics. The clinic’s base fee is typically $10,000–$20,000; medications add $3,000–$7,000; and genetic testing of embryos (PGT-A) adds another $3,000–$10,000. The catch is the word “single” — most patients need more than one cycle, so the real budget is a multiple of the sticker.

Egg freezing. One retrieval-and-freeze cycle averages $10,000 to $20,000 including medications, plus annual storage fees that run $500 to $1,000 a year. Because the average woman needs roughly two cycles to bank enough eggs, the all-in cost frequently lands north of $20,000 before a single baby is on the table.

Surrogacy. This is the tool that separates the merely comfortable from the wealthy. A full surrogacy journey in the U.S. in 2025 runs roughly $120,000 to $220,000 all-in, according to multiple 2025 cost breakdowns. Of that, the agency fee alone is typically $35,000–$55,000, the carrier’s compensation makes up 35–45% of the total, and the rest goes to IVF, legal work, escrow, and insurance. In surrogacy-friendly, high-demand states like California, the top of the range pushes toward $200,000.

Two things push the surrogacy number higher still. If the intended mother’s eggs won’t work, donor eggs add roughly $20,000–$45,000 for an agency-sourced donor and her cycle. And if a first embryo transfer fails, the family often pays for another — surrogacy contracts are usually written around a set number of transfer attempts, and each additional one carries its own medical bill. The “$120K–$220K” range assumes things go reasonably smoothly; they don’t always.

That’s the answer to the Million Dollar Question: a surrogacy journey costs about as much as a starter home in much of the country — option B.

Hidden costs and tradeoffs

The sticker prices understate the real burden in three ways.

First, you rarely pay once. IVF is sold as a cycle, but the odds are set per attempt, so most families run several. Egg freezing averages about two retrieval cycles to bank a usable number of eggs, and freezing eggs is no guarantee they’ll ever produce a baby. A budget built around one cycle is almost always wrong.

Second, the storage bills never stop. Frozen eggs and embryos sit in tanks accruing annual fees for as long as you keep them — a small line item that runs for years and occasionally triggers wrenching decisions about embryos a family no longer intends to use.

Third, and least visible on any invoice, is the emotional and physical toll. Hormone stimulation is physically demanding; failed transfers and miscarriages are common and quietly devastating; and the whole process can stretch over years. Money smooths the logistics and removes the financial panic, but it does not make a failed cycle hurt less. Wealthy families get more attempts, which can mean more disappointments before a success — the cost of buying probability is that you keep playing.

There’s also a cost-arbitrage temptation that cuts against all of this. Because U.S. surrogacy is so expensive, some families look abroad, where a full journey can run a fraction of the domestic price. But the savings are often illusory once you price in the legal risk, the travel, and the possibility that the destination country changes its rules mid-process — which, as the past few years have shown, happens. The families best positioned to absorb a surprise are, again, the wealthiest ones, which is why the cheapest-looking path is frequently the one that only makes sense for people who least need to economize.

For surrogacy there’s a fourth layer: cross-border legal risk. Families that pursue surrogacy abroad to save money or find a carrier faster can run into countries where the arrangement isn’t recognized, leaving a newborn temporarily stateless or a parent without legal standing. The trend since 2020 has been toward restriction: India limited surrogacy to altruistic arrangements for its own citizens and barred foreigners, Italy extended its ban extraterritorially in 2024, and Ukraine — long a high-volume destination — became far riskier amid war. This is a domain where the value of good lawyers, and the budget to stay inside surrogacy-friendly U.S. states, is easy to underestimate.

What people get wrong

The biggest misconception is that a clinic’s advertised success rate tells you your odds. It doesn’t. Clinics report outcomes to the [CDC and to SART](https://rscbayarea.com/article/inte